Escozine Immunapen drops are venom based immune boosters that contain a patented polarized solution of Rhopalurus princeps scorpion venom. It is derived from a proprietary formulation found in its lead drug candidate Escozine, which includes a small molecular peptide found in scorpions that is then polarized through a patented process. The formulation is designed to enhance the user’s immune system while providing an energy booster that increases the overall quality of life. Its new and improved pen design is easy-to-use and can be carried on the go.
Venom therapies and treatments have been used for centuries by indigenous people and now have been widely adopted by the medical community as treatments to aid in reducing inflammation, pain and modulating immune response. Promoters of this product claim that Immunapen drops;
- Focuses on full immune health and function
- Helps to improve energy
- Helps to promote more restful sleep
Currently, animal venom components are being used as valuable and powerful pharmacological tools. Venom derived-drugs have been produced by the pharmaceutical industry since the 1970’s. Current pharmaceuticals utilize snake, scorpion, snail, and sea anemone venom components. These highly regarded medicines are used to treat cancer, high blood pressure, auto immune disease, MS and HIV.
Polarized Active Ingredients: Rhopalurus princeps venom-3x Silica-30C
Inactive Ingredients: Medical-grade Distilled Water.
Escozine Immunapen drops are produced by Medolife Rx, Inc. (“Medolife”), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc.
How Escozine Immunapen Drops Work
The Rhopalurus princeps venom contains a small molecular peptide that can pass through the blood-brain barrier in the body. Four small molecular peptides in the venom can attack various diseases in humans. To do this, it blocks small‐conductance chloride, sodium, potassium and calcium ion channels, and it also binds preferentially to abnormal and cancerous cells, leaving the normal cells intact. Medolife holds exclusive rights to the Rhopalurus princeps scorpion per the agreement signed with the Ministry of Environment and Natural Resources of the Dominican Republic.
Are Escozine Immunapen Drops Safe To Use?
This medication is generally considered safe when taken in the recommended amount. A safety and toxicity study conducted on Escozine showed no signs of toxicity in any of the patients involved in the study who were given the drug.
The study, which was conducted in Santo Domingo of the Dominican Republic under the supervision of medical principal investigators, was conducted on over 500 patients, where data from one group of patients was used in the Company’s FDA pre-IND filing.
Each patient was given Escozine sublingually four times a day. During and after administration, a complete blood count (CBC) was conducted on each patient where the researchers measured various parameters to evaluate if the drug candidate was safe, such as hemoglobin (Hb), hematocrit (HCT), and red blood cells (RBCs) levels. There were no significant differences observed before or after administration.
Additionally, there were no significant differences observed in white blood cells (WBCs), neutrophils, lymphocytes, monocytes, or eosinophils, concluding that Escozine was safe and non-toxic.
However, there is scarcity of information about the possible side effects of Escozine Immunapen drops. Allergic reactions to the venom in susceptible people may result in a potentially life-threatening reaction known as anaphylaxis. The World Allergy Organization estimates that 1% to 7% of the general population have allergic reactions to insect venoms.
